Mice Model Market is expected to reach USD 2,615.60 million by 2032 due to increasing biomedical research activities

The global mice model market size was worth around USD 1,434.80 million in 2023 and is predicted to grow to around USD 2,615.60 million by 2032 with a compound annual growth rate (CAGR) of roughly 6.90% between 2024 and 2032.

Mice models are laboratory animals used as important tools in biomedical research, drug development, and genetic studies. These animals share about 95% of their genes with humans, making them extremely useful for studying diseases and testing new treatments before human trials. Scientists work with different types of mice, such as inbred strains, outbred stocks, genetically modified mice, and immunodeficient models, to answer specific scientific questions. Mice are widely used because they reproduce quickly, are easy to maintain, and have well-understood genomes that allow precise genetic changes. Researchers can create mouse models that closely resemble human conditions like cancer, diabetes, neurological disorders, and heart diseases. These models help scientists observe how diseases develop, check if drugs are safe and effective, and study basic biological processes in controlled environments. Advances in genetic engineering continue to improve how mice models are created and used across many research areas.

Browse the full “Mice Model Market By Technology (Nuclear Transfer, Embryonic Stem Cell Injection, Microinjection, CRISPR, and Others), By Mice (Hybrid, Knockout, Outbred, Inbred, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2024 - 2032” Report at https://www.zionmarketresearch.com/report/mice-model-market-size

The growth of the global mice model industry is primarily driven by the expanding pharmaceutical pipeline requiring extensive preclinical evaluation, technological advances in genetic modification techniques, and increasing regulatory requirements for animal testing before human clinical trials.

Market Growth Factors

Several factors are propelling the expansion of the mice model market.

• Increasing research funding: Rising global investment in medical and scientific research is driving greater demand for reliable animal models, as laboratories require mice to study diseases, evaluate new treatments, and generate early safety data before moving to clinical trials.
• Genetic engineering innovations: CRISPR-Cas9 and other gene-editing tools allow scientists to create precise mouse models with specific genetic changes, improving disease simulation and reducing development time for specialized research animals.
• Cancer research expansion: Growing oncology research increases the need for immunodeficient and patient-derived xenograft mice, helping scientists study human tumor behavior and test new cancer treatments in human beings.

Restraints

• Ethical concerns: Animal welfare groups raise issues about using animals in research, resulting in stricter regulations, more documentation, and longer approval processes for studies involving mice.
• Alternative testing methods: New technologies like organ-on-chip platforms, 3D cell cultures, and computer-based models offer non-animal testing options that may reduce reliance on mouse models as they gain validation and regulatory support.

Mice Model Market: Report Scope

Market Segmentation

The mice model market can be segmented by model type, technology, application, end-user, and region.

Based on model type, the market is divided into inbred mice, outbred mice, genetically engineered mice, immunodeficient mice, and hybrid mice. Genetically engineered mice are expected to maintain a significant market share during the forecast period due to their ability to precisely replicate human genetic conditions and disease states for targeted research applications.

Based on technology, the mice model market is segmented into CRISPR-Cas9, embryonic stem cell injection, nuclear transfer, microinjection, and other genetic modification techniques. CRISPR-Cas9 is expected to lead the market during the forecast period due to its efficiency, accuracy, and cost-effectiveness.

Based on application, the mice model industry is categorized into oncology research, immunology studies, neuroscience research, cardiovascular disease research, and metabolic disorder studies. Oncology research leads the market due to the critical need for preclinical cancer models predicting human tumor behavior and therapeutic responses.

Based on end-user, the market is classified into pharmaceutical companies, biotechnology firms, academic and research institutions, and contract research organizations. Academic and research institutions lead the market by conducting fundamental biological research and early-stage disease investigations.

North America leads the global mice model market because it has strong research facilities and major government support for biomedical science. The region is home to top universities and research centers with advanced animal labs and genetic engineering tools. These institutions benefit from clear regulations, skilled scientists, and strong partnerships between universities and industry. Large research budgets, including major funding from the National Institutes of Health, support many projects that rely on animal models. Biotechnology startups and major pharmaceutical companies create steady demand for mice models across the United States and Canada. Strong intellectual property laws and well-developed breeding facilities also help maintain a reliable supply of research animals. Ongoing investments in new technologies continue to strengthen the region’s leadership in this market.

Key Market Players

Leading companies operating in the global mice model market include:

• Cyagen Biosciences
• Charles River Laboratories
• Ozgene
• The Jackson Laboratory
• Labcorp Drug Development
• Taconic Biosciences
• Champions Oncology
• Horizon Discovery
• Envigo
• Harbor BioMed
• Pharmaron
• GenOway
• Biocytogen
• Crown Bioscience
• Trans Genic Inc.

Recent Developments

• In March 2025, Colossal Biosciences announced the creation of a “woolly mouse”, a genetically-engineered mouse with mammoth-like fur and fat-metabolism traits, as a step toward enhanced animal models.
• In July 2025, Taconic Biosciences launched a new humanized transferrin receptor (hTFRC) mouse model designed for central nervous system therapeutics, showcasing next-generation precision model offerings.

The global mice model market is segmented as follows:

By Technology

• Nuclear Transfer
• Embryonic Stem Cell Injection
• Microinjection
• CRISPR
• Others

By Mice

• Hybrid
• Knockout
• Outbred
• Inbred
• Others

​By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com